Total income stood at Rs 864.56 crore for the quarter under consideration, up 12.89 per cent, as against Rs 765.80 crore for the same perio...

As per the terms of the agreement, Wockhardt has reserved manufacturing capacity to allow for the supply of multiple vaccines to the UK gov...

Drug firm Wockhardt today reported a 25.88 per cent rise in consolidated net profit to Rs 42.90 crore for the quarter ended March 31.

The company had posted a net profit of Rs 3.63 crore during the corresponding period of the previous fiscal, Wockhardt said in a filing to ...

Pharma firm Wockhardt will continue to strengthen its R&D capabilities to develop innovative and technologically advanced medicines, a top ...

Mumbai-based pharmaceutical company Wockhardt has appointed Zoher Sihorwala to head its regulatory and compliance division, a senior execut...

The stock is now locked in lower circuit at Rs 499.30. It has lost nearly 10% in the month of October as compared to over 60% fall so far i...

The impact of the same on existing business will only be known once the company receives further communication from UKMHRA, Wockhardt said.

Net sales rose to Rs 1,358.37 crore for the first quarter, compared to Rs 1,341.44 crore during the same period of previous fiscal.

Drug firm Wockhardt today said UK Medicines and MHRA has imposed an import alert on Wockhardt's export-oriented Unit plant at Waluj in Maha...

The company had posted a net profit of Rs 213 crore in the same period of previous fiscal.

The company's consolidated revenues grew by 35% at Rs 1426 cr as against Rs 1053 cr last year, during the same quarter.

The Mumbai-based company had posted a net loss of Rs 189.87 crore in the corresponding quarter of the previous fiscal.

Domestic pharma major Wockhardt has decided to enter the lucrative contract manufacturing (CRAM) space from the next fiscal.

Wockhardt has acquired Negma Laboratories in cash - a deal that would give it access to the European mkt.

Mumbai-based pharmaceutical firm Wockhardt on Tuesday said the company has acquired Pinewood Laboratories, one of the largest and fastest g...

The acquisition is a strategic fit for Wockhardt UK as Pinewood's liquids and creams business complements its strengths in injectable and s...